BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22464347)

  • 1. MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis.
    Ibarrola-Villava M; Hu HH; Guedj M; Fernandez LP; Descamps V; Basset-Seguin N; Bagot M; Benssussan A; Saiag P; Fargnoli MC; Peris K; Aviles JA; Lluch A; Ribas G; Soufir N
    Eur J Cancer; 2012 Sep; 48(14):2183-91. PubMed ID: 22464347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.
    Nan H; Kraft P; Hunter DJ; Han J
    Int J Cancer; 2009 Aug; 125(4):909-17. PubMed ID: 19384953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population.
    Guedj M; Bourillon A; Combadières C; Rodero M; Dieudé P; Descamps V; Dupin N; Wolkenstein P; Aegerter P; Lebbe C; Basset-Seguin N; Prum B; Saiag P; Grandchamp B; Soufir N;
    Hum Mutat; 2008 Sep; 29(9):1154-60. PubMed ID: 18683857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas.
    Helsing P; Nymoen DA; Rootwelt H; Vårdal M; Akslen LA; Molven A; Andresen PA
    Genes Chromosomes Cancer; 2012 Jul; 51(7):654-61. PubMed ID: 22447455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
    Quint KD; van der Rhee JI; Gruis NA; Ter Huurne JA; Wolterbeek R; van der Stoep N; Bergman W; Kukutsch NA
    Acta Derm Venereol; 2012 Nov; 92(6):587-92. PubMed ID: 22965007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of three important genes in pigmentation and melanoma susceptibility: CDKN2A, MC1R and HERC2/OCA2.
    Ibarrola-Villava M; Fernandez LP; Pita G; Bravo J; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G
    Exp Dermatol; 2010 Sep; 19(9):836-44. PubMed ID: 20629734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
    Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
    Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
    Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
    J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population.
    Stratigos AJ; Dimisianos G; Nikolaou V; Poulou M; Sypsa V; Stefanaki I; Papadopoulos O; Polydorou D; Plaka M; Christofidou E; Gogas H; Tsoutsos D; Kastana O; Antoniou C; Hatzakis A; Kanavakis E; Katsambas AD
    J Invest Dermatol; 2006 Aug; 126(8):1842-9. PubMed ID: 16601669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.
    Scherer D; Nagore E; Bermejo JL; Figl A; Botella-Estrada R; Thirumaran RK; Angelini S; Hemminki K; Schadendorf D; Kumar R
    Int J Cancer; 2009 Oct; 125(8):1868-75. PubMed ID: 19585506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin Pigmentation Genetics for the Clinic.
    Ainger SA; Jagirdar K; Lee KJ; Soyer HP; Sturm RA
    Dermatology; 2017; 233(1):1-15. PubMed ID: 28463841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.
    Kennedy C; ter Huurne J; Berkhout M; Gruis N; Bastiaens M; Bergman W; Willemze R; Bavinck JN
    J Invest Dermatol; 2001 Aug; 117(2):294-300. PubMed ID: 11511307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
    Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.
    Bastiaens MT; ter Huurne JA; Kielich C; Gruis NA; Westendorp RG; Vermeer BJ; Bavinck JN;
    Am J Hum Genet; 2001 Apr; 68(4):884-94. PubMed ID: 11254446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma.
    Gudbjartsson DF; Sulem P; Stacey SN; Goldstein AM; Rafnar T; Sigurgeirsson B; Benediktsdottir KR; Thorisdottir K; Ragnarsson R; Sveinsdottir SG; Magnusson V; Lindblom A; Kostulas K; Botella-Estrada R; Soriano V; Juberías P; Grasa M; Saez B; Andres R; Scherer D; Rudnai P; Gurzau E; Koppova K; Kiemeney LA; Jakobsdottir M; Steinberg S; Helgason A; Gretarsdottir S; Tucker MA; Mayordomo JI; Nagore E; Kumar R; Hansson J; Olafsson JH; Gulcher J; Kong A; Thorsteinsdottir U; Stefansson K
    Nat Genet; 2008 Jul; 40(7):886-91. PubMed ID: 18488027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.
    Kanetsky PA; Ge F; Najarian D; Swoyer J; Panossian S; Schuchter L; Holmes R; Guerry D; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):808-19. PubMed ID: 15159314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population.
    Córdoba-Lanús E; Hernández-Jiménez JG; Medina-Coello C; Espinoza-Jiménez A; González A; Rodríguez-Pérez MD; Carretero-Hernández G; Almeida P; Suárez-Hernández J; Perera-Molinero A; Fernández-de-Misa R
    Arch Dermatol Res; 2014 Jan; 306(1):51-8. PubMed ID: 24170137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions by MC1R Variants to Melanoma Risk in Males and Females.
    Wendt J; Mueller C; Rauscher S; Fae I; Fischer G; Okamoto I
    JAMA Dermatol; 2018 Jul; 154(7):789-795. PubMed ID: 29898205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
    Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
    Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A large French case-control study emphasizes the role of rare Mc1R variants in melanoma risk.
    Hu HH; Benfodda M; Dumaz N; Gazal S; Descamps V; Bourillon A; Basset-Seguin N; Riffault A; Ezzedine K; Bagot M; Bensussan A; Saiag P; Grandchamp B; Soufir N
    Biomed Res Int; 2014; 2014():925716. PubMed ID: 24982914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.